These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32381545)

  • 41. Diffuse intrinsic pontine glioma ventricular peritoneal shunt metastasis: a case report and literature review.
    Gelder CL; Hawkins C; Zapotocky M; Dirks P; Bartels U; Bouffet E
    Childs Nerv Syst; 2019 May; 35(5):861-864. PubMed ID: 30706132
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diffuse Intrinsic Pontine Glioma: Time for Cautious Optimism.
    Hennika T; Becher OJ
    J Child Neurol; 2016 Oct; 31(12):1377-85. PubMed ID: 26374787
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
    Cooney TM; Cohen KJ; Guimaraes CV; Dhall G; Leach J; Massimino M; Erbetta A; Chiapparini L; Malbari F; Kramer K; Pollack IF; Baxter P; Laughlin S; Patay Z; Young Poussaint T; Warren KE
    Lancet Oncol; 2020 Jun; 21(6):e330-e336. PubMed ID: 32502459
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characteristics of patients ≥10 years of age with diffuse intrinsic pontine glioma: a report from the International DIPG/DMG Registry.
    Erker C; Lane A; Chaney B; Leary S; Minturn JE; Bartels U; Packer RJ; Dorris K; Gottardo NG; Warren KE; Broniscer A; Kieran MW; Zhu X; White P; Dexheimer PJ; Black K; Asher A; DeWire M; Hansford JR; Gururangan S; Nazarian J; Ziegler DS; Sandler E; Bartlett A; Goldman S; Shih CS; Hassall T; Dholaria H; Bandopadhayay P; Samson Y; Monje M; Fisher PG; Dodgshun A; Parkin S; Chintagumpala M; Tsui K; Gass D; Larouche V; Broxson E; Garcia Lombardi M; Wang SS; Ma J; Hawkins C; Hamideh D; Wagner L; Koschmann C; Fuller C; Drissi R; Jones BV; Leach J; Fouladi M
    Neuro Oncol; 2022 Jan; 24(1):141-152. PubMed ID: 34114629
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DECIPHER pooled shRNA library screen identifies PP2A and FGFR signaling as potential therapeutic targets for diffuse intrinsic pontine gliomas.
    Schramm K; Iskar M; Statz B; Jäger N; Haag D; Słabicki M; Pfister SM; Zapatka M; Gronych J; Jones DTW; Lichter P
    Neuro Oncol; 2019 Jul; 21(7):867-877. PubMed ID: 30943283
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Parametric Response Mapping of Apparent Diffusion Coefficient as an Imaging Biomarker to Distinguish Pseudoprogression from True Tumor Progression in Peptide-Based Vaccine Therapy for Pediatric Diffuse Intrinsic Pontine Glioma.
    Ceschin R; Kurland BF; Abberbock SR; Ellingson BM; Okada H; Jakacki RI; Pollack IF; Panigrahy A
    AJNR Am J Neuroradiol; 2015 Nov; 36(11):2170-6. PubMed ID: 26338910
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MR imaging assessment of tumor perfusion and 3D segmented volume at baseline, during treatment, and at tumor progression in children with newly diagnosed diffuse intrinsic pontine glioma.
    Sedlacik J; Winchell A; Kocak M; Loeffler RB; Broniscer A; Hillenbrand CM
    AJNR Am J Neuroradiol; 2013 Jul; 34(7):1450-5. PubMed ID: 23436052
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Repeat convection-enhanced delivery for diffuse intrinsic pontine glioma.
    Bander ED; Ramos AD; Wembacher-Schroeder E; Ivasyk I; Thomson R; Morgenstern PF; Souweidane MM
    J Neurosurg Pediatr; 2020 Dec; 26(6):661-666. PubMed ID: 32977309
    [TBL] [Abstract][Full Text] [Related]  

  • 49. H3.3 K27M depletion increases differentiation and extends latency of diffuse intrinsic pontine glioma growth in vivo.
    Silveira AB; Kasper LH; Fan Y; Jin H; Wu G; Shaw TI; Zhu X; Larson JD; Easton J; Shao Y; Yergeau DA; Rosencrance C; Boggs K; Rusch MC; Ding L; Zhang J; Finkelstein D; Noyes RM; Russell BL; Xu B; Broniscer A; Wetmore C; Pounds SB; Ellison DW; Zhang J; Baker SJ
    Acta Neuropathol; 2019 Apr; 137(4):637-655. PubMed ID: 30770999
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Magnetic resonance spectroscopic detection of lactate is predictive of a poor prognosis in patients with diffuse intrinsic pontine glioma.
    Yamasaki F; Kurisu K; Kajiwara Y; Watanabe Y; Takayasu T; Akiyama Y; Saito T; Hanaya R; Sugiyama K
    Neuro Oncol; 2011 Jul; 13(7):791-801. PubMed ID: 21653595
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative diffusion-weighted and dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging analysis of T2 hypointense lesion components in pediatric diffuse intrinsic pontine glioma.
    Löbel U; Sedlacik J; Reddick WE; Kocak M; Ji Q; Broniscer A; Hillenbrand CM; Patay Z
    AJNR Am J Neuroradiol; 2011 Feb; 32(2):315-22. PubMed ID: 21087935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Magnetic resonance imaging texture analyses in lower-grade gliomas with a commercially available software: correlation of apparent diffusion coefficient and T2 skewness with 1p/19q codeletion.
    Kanazawa T; Minami Y; Takahashi H; Fujiwara H; Toda M; Jinzaki M; Yoshida K; Sasaki H
    Neurosurg Rev; 2020 Aug; 43(4):1211-1219. PubMed ID: 31402410
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrated Metabolic and Epigenomic Reprograming by H3K27M Mutations in Diffuse Intrinsic Pontine Gliomas.
    Chung C; Sweha SR; Pratt D; Tamrazi B; Panwalkar P; Banda A; Bayliss J; Hawes D; Yang F; Lee HJ; Shan M; Cieslik M; Qin T; Werner CK; Wahl DR; Lyssiotis CA; Bian Z; Shotwell JB; Yadav VN; Koschmann C; Chinnaiyan AM; Blüml S; Judkins AR; Venneti S
    Cancer Cell; 2020 Sep; 38(3):334-349.e9. PubMed ID: 32795401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Unlocking the translational potential of circulating nucleosomes for liquid biopsy in diffuse intrinsic pontine glioma.
    Lu VM; Power EA; Zhang L; Daniels DJ
    Biomark Med; 2019 Jun; 13(8):597-600. PubMed ID: 31157545
    [No Abstract]   [Full Text] [Related]  

  • 55. Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine Gliomas.
    Koncar RF; Dey BR; Stanton AJ; Agrawal N; Wassell ML; McCarl LH; Locke AL; Sanders L; Morozova-Vaske O; Myers MI; Hamilton RL; Carcaboso AM; Kohanbash G; Hu B; Amankulor NM; Felker J; Kambhampati M; Nazarian J; Becher OJ; James CD; Hashizume R; Broniscer A; Pollack IF; Agnihotri S
    Cancer Res; 2019 Aug; 79(16):4026-4041. PubMed ID: 31201162
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry.
    Gits HC; Anderson M; Stallard S; Pratt D; Zon B; Howell C; Kumar-Sinha C; Vats P; Kasaian K; Polan D; Matuszak M; Spratt DE; Leonard M; Qin T; Zhao L; Leach J; Chaney B; Escorza NY; Hendershot J; Jones B; Fuller C; Leary S; Bartels U; Bouffet E; Yock TI; Robertson P; Mody R; Venneti S; Chinnaiyan AM; Fouladi M; Gottardo NG; Koschmann C
    Acta Neuropathol Commun; 2018 Jul; 6(1):67. PubMed ID: 30049282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003.
    Kline C; Jain P; Kilburn L; Bonner ER; Gupta N; Crawford JR; Banerjee A; Packer RJ; Villanueva-Meyer J; Luks T; Zhang Y; Kambhampati M; Zhang J; Yadavilli S; Zhang B; Gaonkar KS; Rokita JL; Kraya A; Kuhn J; Liang W; Byron S; Berens M; Molinaro A; Prados M; Resnick A; Waszak SM; Nazarian J; Mueller S
    Clin Cancer Res; 2022 Sep; 28(18):3965-3978. PubMed ID: 35852795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predicting Genotype and Survival in Glioma Using Standard Clinical MR Imaging Apparent Diffusion Coefficient Images: A Pilot Study from The Cancer Genome Atlas.
    Wu CC; Jain R; Radmanesh A; Poisson LM; Guo WY; Zagzag D; Snuderl M; Placantonakis DG; Golfinos J; Chi AS
    AJNR Am J Neuroradiol; 2018 Oct; 39(10):1814-1820. PubMed ID: 30190259
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.
    Goyal A; Yolcu YU; Goyal A; Kerezoudis P; Brown DA; Graffeo CS; Goncalves S; Burns TC; Parney IF
    Neurosurg Focus; 2019 Dec; 47(6):E13. PubMed ID: 31786548
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High Prevalence of Developmental Venous Anomaly in Diffuse Intrinsic Pontine Gliomas: A Pediatric Control Study.
    Roux A; Boddaert N; Grill J; Castel D; Zanello M; Zah-Bi G; Chrétien F; Lefevre E; Ros VD; Zerah M; Puget S; Pallud J; Varlet P
    Neurosurgery; 2020 Apr; 86(4):517-523. PubMed ID: 31342064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.